DJ Regeneron Pharmaceuticals Inc. Stock Outperforms Competitors On Strong Trading Day
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Regeneron Pharmaceuticals Inc. $(REGN)$ rallied 2.23% to $568.20 Thursday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index rising 0.85% to 6,587.47 and the Dow Jones Industrial Average rising 1.36% to 46,108.00.
The stock's rise snapped a three-day losing streak.
Regeneron Pharmaceuticals Inc. closed 51.46% short of its 52-week high of $1,170.58, which the company achieved on September 13th.
The stock demonstrated a mixed performance when compared to some of its competitors Thursday, as Amgen Inc. $(AMGN)$ rose 1.52% to $282.73, Moderna Inc. (MRNA) rose 4.44% to $25.39, and Gilead Sciences Inc. (GILD) rose 2.26% to $117.86.
Trading volume (863,679) remained 102,310 below its 50-day average volume of 965,989.
Data source: Dow Jones Market Data, FactSet. Data compiled September 11, 2025.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
September 11, 2025 16:46 ET (20:46 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.